{
    "nctId": "NCT01332916",
    "briefTitle": "Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging",
    "officialTitle": "Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Healthy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Assess the relationship between memory impairment and brain dysfunction",
    "eligibilityCriteria": "Inclusion Criteria for patients:\n\n* Patients aged 45 and over\n* Patients from Grade 3 'end of primary schooling \"minimum (scale Barbizet)\n* Non-Metastatic Breast Cancer\n* Adjuvant Chemotherapy: FEC, including Docetaxel Protocols\n* No major cognitive impairment\n* No previous neurological\n* Lack of personality disorders and psychiatric disorders evolutionary\n* Having signed the informed consent of study participation\n\nInclusion Criteria for control group:\n\n* Women from the general population aged 45 and over, and matched in age and cultural level in patients\n* Topics of Grade 3 'end of primary schooling \"minimum (scale Barbizet)\n* No prior cancer\n* No major cognitive impairment\n* No previous neurological\n* Lack of personality disorders and psychiatric disorders evolutionary\n* Participating in the IMAP Protocol No. ID-BCR: 2007-A00414-49 or IMAP+(n\u00b0 ID RCB 2011-A01493-38)(see how the study below) have signed forms no objection and consent to study participation\n\nExclusion Criteria:\n\nTraduction (fran\u00e7ais \\> anglais)\n\n* Metastatic\n* Cancer of the breast other than primitive\n* Patients with paraneoplastic syndrome\n* Patients under 45 years\n* Patients whose achievement is below level 3 'end of primary schooling \"(scale Barbizet)\n* Patients with adjuvant chemotherapy is associated with targeted therapy\n* Patients who have received other cancer treatments (chemotherapy or radiotherapy brain)\n* Contraindication to the implementation of an MRI (claustrophobia, metal objects in the body)\n* disorders of higher functions existing in the administration of chemotherapy\n* Neurologic earlier\n* Pathology psychiatric evolutionary\n* Refusal of participation\n* Patients unable to meet the cognitive tests\n* Drug use\n* Heavy drinking",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}